Kitazato

Kitazato Net Margin

The Net Profit Margin of Kitazato (368A.T) as of Nov 17, 2026 is 36.77 %. In the previous year, Net Profit Margin was 39.40 % — a change of -6.69% (lower).

Net Margin

36.77 %

YoY

-6.69%

Last updated:

Net Profit Margin of Kitazato is 2025 36.77 % . Net Profit Margin of Kitazato was 2024 39.40 % . It decreases by -6.69% lower compared to the previous year.

Kitazato's net margin stands at 36.8%, broadly stable from 36.1% several years earlier.

The Kitazato Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2023
36.05 JPY
Jan 1, 2024
39.40 JPY
Jan 1, 2025
36.77 JPY
The Kitazato Net Margin history
YEARNet MarginYoY
36.77 %-6.69%
39.40 %+9.30%
36.05 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Kitazato Stock analysis

What does Kitazato do? Kitazato Corp manufactures and sells medical devices, reagents, and related products for infertility treatment, specializing in reproductive engineering technology for artificial insemination, in vitro fertilization, and cell cryopreservation. The company produces consumables such as medical equipment and reagents used in in vitro fertilization and intracytoplasmic sperm injection, including media, cryo devices, medical devices, and micro tools. Kitazato Corp distributes its products globally, serving markets in Japan, Europe, the United States, China, and India, with a focus on research reagents and medical equipment for infertility treatment. The firm also manufactures and sells medical equipment parts, provides genetic testing services, and offers medical equipment for the elderly. Additionally, Kitazato Corp engages in market research, acquisition of local licenses, and contract management of living cells, expanding its reach into regenerative medicine and related fields. These services and products target healthcare providers, fertility clinics, and research institutions worldwide. Kitazato Corp's revenue streams include the sale of consumables, medical devices, and reagents, as well as genetic testing and contract management services. The company's global distribution network supports sales across key regions, with a strong emphasis on infertility treatment solutions and regenerative medicine technologies. Kitazato is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kitazato stock

Net Profit Margin of Kitazato is 36.77 % in 2025.

Net Profit Margin of Kitazato changed from 39.40 % to 36.77 %, representing a -6.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Kitazato since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Kitazato with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Kitazato

All Key Metrics — Kitazato